Deutsche Bank
ETTX

Deutsche Bank’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Deutsche Bank’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-208
Closed – – 5523
2018
Q4 		$0 Buy
+208
New +$1.37K ﹤0.01% 5529

Other funds holding ETTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's ETTX Position: Q1 2019 in Review

Deutsche Bank sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2019, closing a stake of 208 shares.

Deutsche Bank first reported a position in ETTX in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 17 funds tracked by Wall St. Rank hold ETTX as of Q1 2019.

  • Deutsche Bank reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2019 after selling out during the quarter.
  • Deutsche Bank sold 208 Entasis Therapeutics Holdings Inc. shares in Q1 2019.
  • Deutsche Bank first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2018 and held it in 1 quarter.
  • Deutsche Bank's Entasis Therapeutics Holdings Inc. position peaked at $0 in Q4 2018.
  • 17 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2019.

Based on Deutsche Bank's 13F filing for Q1 2019, filed 15 May 2019.